Cytoprotector developed by Obninsk scientists protected by Russian patent No. 2451680 received a diploma from the Federal Intellectual Property Service as one of 100 Best Inventions of Russia in 2012.
Recently an official award ceremony has been held within the framework of Intellectual Property Week. the awards were given to patent holders whose inventions were included in 2012 TOP-100. Medbiofarm Scientific and research Company OOO was among them.
The cytoprotector is intended to minimize side effects of chemotherapy and X-Ray therapy, first of all, for oncologic patients and increase the treatment efficiency.